切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2023, Vol. 10 ›› Issue (04) : 258 -263. doi: 10.3877/cma.j.issn.2095-7157.2023.04.005

论著

一种新型乳链菌素混合物体外杀灭幽门螺杆菌的实验研究
高明生, 张盼盼, 包楠迪, 孟繁森, 李婷婷, 徐世平()   
  1. 100853 北京,解放军总医院研究生院;100853 北京,解放军总医院第二医学中心消化内科、国家老年疾病临床研究中心
    100048 北京,解放军总医院第六医学中心心血管医学部
    100853 北京,解放军总医院第二医学中心消化内科、国家老年疾病临床研究中心
  • 收稿日期:2023-09-07 出版日期:2023-11-15
  • 通信作者: 徐世平
  • 基金资助:
    军队保健科研课题(18BJZ22)

Experimental study on killing Helicobacter pylori in vitro by a new mixture of Nisin

Mingsheng Gao, Panpan Zhang, Nandi Bao, Fansen Meng, Tingting Li, Shiping Xu()   

  1. Graduate School of PLA General Hospital, Beijing 100853, China; Department of Gastroenterology, The Second Medical Center of Chinese PLA General Hospital; National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China
    Senior Department of Cardiology, The Sixth Medical Center of Chinese PLA General Hospital, Beijing 100048, China
    Department of Gastroenterology, The Second Medical Center of Chinese PLA General Hospital; National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2023-09-07 Published:2023-11-15
  • Corresponding author: Shiping Xu
引用本文:

高明生, 张盼盼, 包楠迪, 孟繁森, 李婷婷, 徐世平. 一种新型乳链菌素混合物体外杀灭幽门螺杆菌的实验研究[J/OL]. 中华胃肠内镜电子杂志, 2023, 10(04): 258-263.

Mingsheng Gao, Panpan Zhang, Nandi Bao, Fansen Meng, Tingting Li, Shiping Xu. Experimental study on killing Helicobacter pylori in vitro by a new mixture of Nisin[J/OL]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(04): 258-263.

目的

研究新型乳链菌素混合物和A型乳链菌素对幽门螺杆菌(Hp)体外杀灭作用并评估新型乳链菌素混合物的杀菌效果。

方法

(1)实验选取Hp标准株NCTC 11637和临床株C27、临床株C28三种菌株。将相同浓度下A型乳链菌素和新型乳链菌素混合物以及空白对照组作用于Hp 2 h,培养4 d后分别记录各实验组以及空白对照组的菌群生长情况;(2)采用临界稀释法检测新型乳链菌素混合物对Hp标准株NCTC 11637和临床株的最低抑菌浓度(MIC)以及最低杀菌浓度(MBC),采用纸片扩散法测定新型乳链菌素混合物的抑菌直径;(3)探究盐酸酸化对新型乳链菌素混合物的影响;(4)用E-test法进行抗生素药敏检测。

结果

(1)相同浓度下,与A型乳链菌素组相比新型乳链菌素混合物组有杀菌作用;(2)新型乳链菌素混合物的MIC在不同的Hp菌株中存在差异,数值在16~32 IU/ml之间,MBC相同为32 IU/ml。新型乳链菌素混合物对Hp标准株NCTC 11647、临床株C27、临床株C28的抑菌直径在3.3 cm~3.8 cm之间;(3)盐酸酸化不影响新型乳链菌素混合物的杀菌作用;(4)新型乳链菌素混合物与四环素有协同杀灭Hp的效果,但与甲硝唑协同效果不明显。

结论

本实验条件下新型乳链菌素混合物对Hp有良好的杀灭作用,且有良好的耐酸性,与四环素有协同杀灭Hp的效果,有望为抗生素协同疗法根治Hp感染提供新的途径。

Objective

To study the in vitro killing of Helicobacter pylori by a novel Nisin mixture and type A Nisin and to evaluate the bactericidal efficacy of the novel Nisin mixture.

Methods

(1)Three strains of Hp standard strain NCTC 11637, clinical strain C27 and clinical strain C28 were selected in the experiment.The same concentration of type A Nisin, new Nisin mixture and blank control group were applied to H. pylori for two hours, and the growth of bacteria in each experimental group and blank control group was recorded after four days of incubation; (2)The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the new nisin mixture against Hp standard strain NCTC 11637 and clinical strains were detected by critical dilution method, and the antibacterial diameter of the new nisin mixture was determined by disk diffusion method; (3)To investigate the effect of hydrochloric acid acidification on the novel Nisin mixture; (4)Antibiotic drug sensitivity testing was carried out by the E-test method.

Results

(1)At the same concentration, the novel Nisin mixture group had a bactericidal effect compared with the type A Nisin group; (2)The MIC of novel Nisin mixture varied in different H. pylori strains, with values between 16 IU/ml to 32 IU/ml, and the MBC was the same at 32 IU/ml.the inhibitory diameters of novel Nisin mixture against Hp standard strain NCTC 11637, clinical strain C27 and clinical strain C28 ranged from 3.3 cm to 3.8 cm; (3)Hydrochloric acid acidification did not affect the bactericidal effect of novel Nisin mixture; (4)novel Nisin mixture has synergistic effect with tetracycline to kill HP, but the synergistic effect with metronidazole is not obvious.

Conclusion

The novel Nisin mixture has good killing effect on H. pylori under the present experimental conditions and good acid resistance, and it has synergistic effect with tetracycline to kill Hp, which is expected to provide a new way for antibiotic synergistic therapy to eradicate H. pylori infection.

表1 标准株NCTC 11637、临床株C27、临床株C28的MIC、MBC
图1 标准株NCTC 11637、临床株C27、临床株C28抑菌直径
表2 标准株NCTC 11637、临床株C27、临床株C28的抑菌直径
图2 甲硝唑和四环素药敏结果注:A:新型Nisin混合物对甲硝唑结果4 ~6 μg/ml; B:对照组对甲硝唑结果4 ~6 μg/ml;C:新型Nisin混合物对四环素结果0.25~0.38 μg/ml; D:对照组对四环素结果0.38~0.50 μg/ml
表3 酸化对新型Nisin混合物的影响
表4 新型Nisin混合物对抗生素药敏的影响
[1]
Matsuoka KNishiumi SYoshida M,et al.Effects of Helicobacter pylori on the glutathione-related pathway in gastric epithelial cells [J]. Biochem Biophys Res Commun2020526(4):1118-1124.
[2]
简文华,李清秀,何朝晖.幽门螺杆菌治疗的研究新进展[J].大医生2023, 8(8): 131-134.
[3]
周汀,刘斌,李善高.幽门螺杆菌感染治疗的研究进展[J].国际消化病杂志2021, 41(2): 96-99.
[4]
崔艳艳,柯希权,王启之,等.安徽省皖北地区120例消化道疾病患者幽门螺杆菌耐药性研究[J].中华全科医学202220(11):1852-1855.
[5]
Savoldia ACarrara EGraham DY,et al.Prevalence of Antibiotic Resistance in Helicobacter pylori:A Systematic Review and Meta-analysis in World Health Organization Regions[J].Gastroenterology2018155(5):1372-1382; 1372-1382,e17.
[6]
陈煜杉,黄雪平,林志辉.幽门螺杆菌对3种常用抗生素的体外耐药情况分析[J].福建医药杂志202244(1):14-18.
[7]
Liu WHansen JN.Some chemical and physical properties of nisin, a small-protein antibiotic produced by Lactococcus lactis[J].Appl Environ Microbiol1990, 56(8): 2551-2558.
[8]
李红,赵春燕.乳酸链球菌素的研究进展[J].食品科技20061:75-78.
[9]
李江阔,张鹏,岳喜庆,等.乳酸链球菌素研究现状及在畜产品加工中的应用[J].保鲜与加工2008, 8(1): 5-8.
[10]
Kim TSHur JWYu MA,et al.Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria[J].J Food prot200366(1):3-12.
[11]
谭瑶,赵清,舒为群,等.K-B纸片扩散法药敏试验[J].检验医学与临床20107(20): 2290-2291.
[12]
张旭阳,李慧,娄亭亭,等.乳酸链球菌素联合次氯酸钠对粪肠球菌的体外抗菌作用研究[J].中国实用口腔科杂志20214(4):456-460.
[13]
曲建平,卢昕,徐文泱.乳酸链球菌素在食品中的应用分析[J].食品安全导刊20226: 175-177.
[14]
章昱,周云芳.细菌素的抗细菌耐药研究及应用现状[J].微生物学免疫学进展201543(6):76-79.
[15]
李静,石璐,刘金,等.乳酸链球菌素联用美罗培南对耐甲氧西林金黄色葡萄球菌的抑菌作用初探[J].天然产物研究与开发202234 (3): 368-374.
[16]
Shin JMGwak JWKamarajan P,et al.Biomedical applicaltions of nisin [J].J Appl Microbiol2016120:1449-1465.
[17]
MengJie WQingLi DXia S,et al.Effective combination of nisin and sesamol against Listeria monocytogenes[J].LWT-Food Sci Technol2023176:114546.
[18]
Ivan SDaragh HMPaula MOC,et al.Nisin E Is a Novel Nisin Variant Produced by Multiple Streptococcus equinus Strains[J].Microorganisms202311(2):427.
[19]
Mengjie WYue MXin D,et al.A review of potential antibacterial activities of nisin against Listeria monocytogenes:the combined use of nisin shows more advantages than single use[J].Food Res Int, 2023164:112363.
[20]
Jiajia WMingwu ZShouwei W,et al.Nisin: From a structural and meat preservation perspective[J].Food Microbiol2023111:104207.
[21]
Abate GYAsfaw ADWodjnew TB,et al.Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System[J].Vet Med (Auckl)202213:173-190.
[22]
Song HZhou LLiu D,et al.Probiotic effect on Helicobacter pylori attachment and inhibition of inflammation in human gastric epithelial cells[J].Exp Ther Med201918(3):1551-162.
[23]
Garcia-Castillo VMarin-Vega AMIlabaca A,et al.Characterization of the immunomodulatory and anti-Helicobacter pylori properties of the human gastric isolate Lactobacillus rhamnosus UCO-25A[J]. Biofouling201935(8): 922-937.
[1] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[2] 崔玉峰, 林毅军, 王志民. 幽门螺杆菌分子检测技术研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 257-262.
[3] 郭伟仪, 林沛玲. 不同抗体型幽门螺杆菌感染与溃疡性结肠炎患者疾病活动及组织学评分的关系[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 237-244.
[4] 沈华娟, 庄剑波, 刘春. 幽门螺杆菌感染抗体分型与胃黏膜炎性病变程度及黏膜组织学变化间的相关性[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 156-162.
[5] 袁柳凤, 徐文绮, 朱小宇, 王慧珠, 伦文辉. 283株淋球菌对七种常见抗菌药物的耐药性分析[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 108-112.
[6] 伍宵, 潘立, 谢理政, 茆翔. 幽门螺杆菌感染和循环miRNA变化与老年脑干出血患者应激性溃疡的关系[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(01): 42-47.
[7] 杨卫东, 周威, 向洪涛. 慢性萎缩性胃炎患者幽门螺杆菌感染与炎性细胞因子及病理特征的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 459-464.
[8] 汤峥丽, 王芳, 王唯坚. 中老年人群幽门螺杆菌感染对非酒精性脂肪肝及冠状动脉粥样硬化影响的关联性分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 137-140.
[9] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[10] 董青, 丁飞, 郭浩, 李峰. Nesfatin-1/NUCB2在幽门螺杆菌感染相关早期胃癌患者中的表达及临床意义[J/OL]. 中华临床医师杂志(电子版), 2023, 17(07): 783-789.
[11] 何妍, 檀丽冰, 周雯, 魏敏, 连军松. 老年男性人群幽门螺杆菌感染与血脂谱的关联研究[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 171-175.
[12] 李志伟, 汤泊夫, 孙鹤, 贾语婧, 江振宇, 刘琳, 李慧, 党彤. 利用探头式共聚焦激光显微内镜荧光定量评价除菌治疗对幽门螺杆菌相关性萎缩性胃炎黏膜屏障功能影响的研究[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 94-99.
[13] 冯建聪, 普布扎西, 大旦增, 宋虎, 彭学成, 程志立, 林杨, 张昊翔. 西藏山南地区幽门螺杆菌感染的单中心分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(01): 37-40.
[14] 薛黎, 高孝忠. 幽门螺杆菌阳性患者服药依从性预测模型的建立[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(01): 23-27.
[15] 蒋琦, 刘卫东, 艾合买江·库尔班江, 惠文佳, 张梦霞, 李紫琼, 高峰. 不同类型幽门螺杆菌合并反流性食管炎的临床病理特征分析[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(02): 95-99.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?